Immunological control of a murine gammaherpesvirus independent of CD8+ T cells

Journal of General Virology

Volumn 80, Issue 2, 1999, Pages 477-483

  Stevenson, P G ^a   Cardin, R D ^a   Christensen, J P ^a   Doherty, P C ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; FEMALE; HERPES VIRUS; IMMUNOREGULATION; LYMPHOCYTE DEPLETION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; THYMECTOMY;

ANIMALIA; DNA VIRUSES; HERPES; HERPESVIRIDAE; MURINAE;

EID: 0033041657     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-80-2-477     Document Type: Article

References (18)

1. + T cells. Journal of Experimental Medicine 184, 863-871.
2. Efstathiou, S., Ho, Y. M., Hall, S., Styles, C. J., Scott, S. D. & Gompels, U. A. (1990). Murine herpesvirus 68 is genetically related to the gammaherpesviruses Epstein-Barr virus and herpesvirus saimiri. Journal of General Virology 71, 1365-1372.
3. Ehtisham, S., Sunil-Chandra, N. P. & Nash, A. A. (1993). Pathogenesis of murine gammaherpesvirus infection in mice deficient in CD4 and CD8 T cells. Journal of Virology 67, 5147-5252.
4. + T cells in major histocompatibility complex class II-deficient mice. Science 253, 1417-1420.
5. + T lymphocytes. Journal of Virology 64, 5457-5464.
6. Jonjic, S., Pavic, I., Polic, B., Crnkovic, I., Lucin, P. & Koszinowski, U. H. (1994). Antibodies are not essential for the resolution of primary cytomegalovirus infection but limit dissemination of recurrent virus. Journal of Experimental Medicine 179, 1713-1717.
7. Kagi, D., Ledermann, B., Burki, K., Seiler, P., Odermatt, B., Olsen, K. J., Podack, E. R., Zinkernagel, R. M. & Hengartner, H. (1994). Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 369, 31-37.
8. Raulet, D.H. (1994). MHC class I-deficient mice. Advances in Immunology 55, 381-421.
9. Rickinson, A. B. & Kieff, E. (1996). Epstein-Barr Virus. In Fields Virology, 3rd edn, pp. 2397-2446. Edited by B. N. Fields, D. M. Knipe & P. M. Howley. Philadelphia: Lippincott-Raven.
10. Stevenson, P. G. & Doherty, P. C. (1998). Kinetic analysis of the host immune response to a murine gammaherpesvirus. Journal of Virology 72, 943-949.
11. Stewart, J. P., Usherwood, E. J., Ross, A. J., Allen, H. & Nash, A. A. (1998). Lung epithelial cells are a major site of murine gammaherpesvirus persistence. Journal of Experimental Medicine 187, 1941-1995.
12. Sunil-Chandra, N. P., Efstathiou, S. & Nash, A.A. (1992). Murine gammaherpesvirus 68 establishes a latent infection in mouse B lymphocytes in vivo. Journal of Virology 73, 3275-3279.
13. Sunil-Chandra, N. P., Arno, J., Fazakerley, J. & Nash, A. A. (1994). Lymphoproliferative disease in mice infected with murine gammaherpesvirus 68. Journal of Pathology 8, 18-826.
14. Usherwood, E. J., Ross, A. J., Allen, D. J. & Nash, A. A. (1996). Murine gammaherpesvirus-induced splenomegaly: a critical role for CD4 T cells. Journal of General Virology 77, 627-630.
15. Usherwood, E. J., Brooks, J. W., Sarawar, S. R., Cardin, R. D., Young, W. D., Allen, D. J., Doherty, P. C. & Nash, A. A. (1997). Immunological control of murine gammaherpesvirus infection is independent of perforin. Journal of General Virology 78, 2025-2030.
16. Virgin, H. W., IV, Latrielle, P., Wamsley, P., Hallsworth, K., Weck, K. E., Dal Canto, A. J. & Speck, S. J. (1997). Complete sequence and genomic analysis of murine gammaherpesvirus 68. Journal of Virology 71, 5894-5904.
17. Weck, K. E., Barkon, M. L., Yoo, L. I., Speck, S. H. & Virgin, H. W. (1996). Mature B cells are required for acute splenic infection but not for establishment of latency by murine gammaherpesvirus 68. Journal of Virology 70, 6775-6780.
18. Weck, K. E., Dal Canto, A. J., Gould, J. D., O'Guin, A. K., Roth, K. A., Saffitz, J. E., Speck, S. H. & Virgin, H. W. (1997). Murine γ-herpesvirus-68 causes severe large-vessel arteritis in mice lacking interferon-γ responsiveness: a new model for virus-induced vascular disease. Nature Medicine 3, 1346-1353.